A Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401
Clinical trial NCT05195541 · COMPLETED
Trial details
- NCT number
- NCT05195541
- Sponsor
- Cutia Therapeutics（Wuxi）Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-27
- Primary completion
- 2022-12-30
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.